2nd February, 2023
In an era of climate change, pressures on water resources and a burgeoning global population reaching 10 billion, indoor vertical farming is emerging to overcome the challenges and address growing food demand.
Subscriber Post
19th November, 2021
The pandemic has fuelled investor interest in biotech, life sciences and drug discovery with state-owned investors ploughing more than US$5.5 billion into the space so far this year, mostly in the form of venture capital for startups – an increase of 53% over the whole of 2020.
Subscriber Post
18th October, 2021
A preliminary agreement for collaboration between G42 Healthcare and Abu Dhabi sovereign wealth fund Mubadala is the latest development in a year that has seen a slew of capital commitments by state-owned investors in the healthcare sector.
Subscriber Post
17th September, 2021
Abu Dhabi sovereign wealth fund is scaling up its plans under the UAE-UK Sovereign Investment Partnership (UAE-UK SIP) with the GBP5 billion (US$7 billion) investment framework agreed in March boosted to GBP10 billion (US$14 billion) over the next five years under a deal signed this week in Downing Street.
Subscriber Post
24th June, 2021
The Covid-19 pandemic has prompted a massive shift in capital towards healthcare, with this week seeing Singaporean sovereign wealth fund GIC invest US$180 million in the healthcare business of Malaysia’s Sunway.
Subscriber Post
25th March, 2021
QIA’s purchase of EUR380 million (US$448 million) of new public equity issued by Siemens Healthineers is the latest and largest single private market transaction by the Qatari fund in the healthcare sector,.
Subscriber Post
24th March, 2021
Britain’s life sciences and renewables sectors gained the backing of Abu Dhabi sovereign wealth fund Mubadala, which is looking to invest up to GBP5 billion in direct investments in private markets through to 2026.
Subscriber Post
13th January, 2021
The first month of 2021 is turning out to be a bumper month for investment by state-owned investors with the volume and value of transactions set to rival the busiest months of 2020 - and potentially see the return of activity to pre-pandemic norms.
Subscriber Post
22nd December, 2020
One of the big winners of Moderna's FDA approval to produce #COVID19 vaccines is no other than the Abu Dhabi Investment Authority (ADIA), who invested US$ 100m in their Series G, pre-IPO round in February 2018.
Subscriber Post